Health & Nutrition
What obesity drugmakers see next in the market: More pills,...
CNBC spoke to executives from Eli Lilly, Novo Nordisk, Pfizer and other drugmakers...
OpenEvidence, the 'ChatGPT for doctors,' doubles valuation...
OpenEvidence, based in Miami, has topped a $12 billion valuation in a funding round...
Amazon launches AI health-care tool for One Medical members
The service uses large language models and references patients medical records to...
Another alliance of health care and AI signals why pharma...
Bristol Myers Squibb and Microsoft's new partnership aimed at accelerating early...
Is Fasting an Effective Treatment for Diabetes?
By losing 15% of their body weight, nearly 90% of those who have had type 2 diabetes...
All About Allulose
Sugar and high fructose corn syrup are the original industrial sweeteners—inexpensive,...
Novo Nordisk shares rise 8% after Wegovy obesity pill has...
The early data is a boost to the Danish drugmaker's hopes of winning back more market...
Healthy Returns: Novo Nordisk CEO on GLP-1 pricing, and...
Novo Nordisk's CEO spoke about GLP-1 pricing and Pfizer's CEO spoke about the company's...
Making U.S. biotech more competitive with China's could...
China is becoming a leader in biotech innovation. That offers hope to rare disease...
Making U.S. biotech more competitive with China's could...
China is becoming a leader in biotech innovation. That offers hope to rare disease...
